세계의 바이오의약품 부형제 시장 규모 조사 : 제품, 기능, 용도 및 지역별 예측(2024-2032년)

Global Biopharmaceutical Excipients Market is valued at approximately USD 2.29 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.75% over the forecast period 2024-2032. Biopharmaceutical excipients are vital non-active substances incorporated into biopharmaceutical formulations to enhance production, stability, usability, and delivery of drugs. They serve various roles such as binders, fillers, diluents, disintegrants, and stabilizers, which are indispensable in drug formulation processes. The market growth is primarily driven by the increasing demand for advanced and functional drug formulations and the rising need for large-molecule development. Investments in drug development are soaring, further boosting the utilization of biopharmaceutical excipients. However, the compatibility issues of biopharmaceutical formulations with active pharmaceutical ingredients pose significant challenges. Additionally, the continuous development of biologics and biosimilars necessitates the integration of compatible excipients. Technological advancements in extended-release formulations and the exploration of alternative routes of administration present significant market expansion potential.

Moreover, carbohydrates are prominent excipients used in pharmaceutical formulations due to their roles in enhancing formulation stability and patient compliance. Various carbohydrates, such as dextrose, starch, and sucrose, offer critical functionalities including bulking agents, fillers, and stabilizers, thereby improving the shelf life and efficacy of biopharmaceuticals. Polyols like mannitol and sorbitol also play essential roles in biopharmaceutical formulations by controlling moisture and improving solubility of active ingredients.

The increasing utilization of preservatives in biologic formulations for improved stability is notable. Binders, coatings, disintegrants, lubricants, glidants, and fillers are essential for ensuring the structural integrity, release mechanisms, and dosage accuracy of pharmaceuticals. Advanced delivery systems are another significant application area, where excipients facilitate the controlled release, targeting, and absorption of biologically active molecules.

The key regions considered for the global Biopharmaceutical Excipients Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Biopharmaceutical Excipients Market in terms of revenue. The market growth in the region is being attributed to factors including robust pharmaceutical industry, significant investment in R&D, and a steady number of FDA approvals. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by rapid growth driven by healthcare initiatives, expanding hospital networks, and the region's growing reputation as a pharmaceutical and biomedical research hub.

Major market players included in this report are:

• BASF SE
• Ashland Global Holdings Inc.
• Roquette Freres S.A.
• Colorcon, Inc.
• Croda International PLC
• The Dow Chemical Company
• Merck KGaA
• Evonik Industries AG
• SPI Pharma, Inc.
• IMCD N.V.

The detailed segments and sub-segments of the market are explained below:

By Product:

• Carbohydrates
• Polyols
• Solubilizers & Surfactants/Emulsifiers
• Specialty Excipients

By Function:

• Binders
• Coatings
• Disintegrants
• Lubricants & Glidants
• Pharmaceutical Fillers
• Preservatives

By Application:

• Advanced Delivery Systems
• Oral
• Parenteral
• Topical

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Biopharmaceutical Excipients Market Executive Summary

• 1.1. Global Biopharmaceutical Excipients Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product
  • 1.3.2. By Function
  • 1.3.3. By Application
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Biopharmaceutical Excipients Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Biopharmaceutical Excipients Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Rising demand for advanced drug formulations
  • 3.1.2. Increasing investment in drug development
  • 3.1.3. Technological advancements in extended-release formulations
• 3.2. Market Challenges
  • 3.2.1. Compatibility issues with active pharmaceutical ingredients
  • 3.2.2. High cost of development
  • 3.2.3. Regulatory constraints
• 3.3. Market Opportunities
  • 3.3.1. Development of biologics and biosimilars
  • 3.3.2. Innovation in excipient technologies
  • 3.3.3. Exploration of alternative routes of administration

Chapter 4. Global Biopharmaceutical Excipients Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Biopharmaceutical Excipients Market Size & Forecasts by Product 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Biopharmaceutical Excipients Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Carbohydrates
  • 5.2.2. Polyols
  • 5.2.3. Solubilizers & Surfactants/Emulsifiers
  • 5.2.4. Specialty Excipients

Chapter 6. Global Biopharmaceutical Excipients Market Size & Forecasts by Function 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Biopharmaceutical Excipients Market: Function Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Binders
  • 6.2.2. Coatings
  • 6.2.3. Disintegrants
  • 6.2.4. Lubricants & Glidants
  • 6.2.5. Pharmaceutical Fillers
  • 6.2.6. Preservatives

Chapter 7. Global Biopharmaceutical Excipients Market Size & Forecasts by Application 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Biopharmaceutical Excipients Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.2.1. Advanced Delivery Systems
  • 7.2.2. Oral
  • 7.2.3. Parenteral
  • 7.2.4. Topical

Chapter 8. Global Biopharmaceutical Excipients Market Size & Forecasts by Region 2022-2032

• 8.1. North America Biopharmaceutical Excipients Market
  • 8.1.1. U.S. Biopharmaceutical Excipients Market
    • 8.1.1.1. Product breakdown size & forecasts, 2022-2032
    • 8.1.1.2. Function breakdown size & forecasts, 2022-2032
    • 8.1.1.3. Application breakdown size & forecasts, 2022-2032
  • 8.1.2. Canada Biopharmaceutical Excipients Market
• 8.2. Europe Biopharmaceutical Excipients Market
  • 8.2.1. U.K. Biopharmaceutical Excipients Market
  • 8.2.2. Germany Biopharmaceutical Excipients Market
  • 8.2.3. France Biopharmaceutical Excipients Market
  • 8.2.4. Spain Biopharmaceutical Excipients Market
  • 8.2.5. Italy Biopharmaceutical Excipients Market
  • 8.2.6. Rest of Europe Biopharmaceutical Excipients Market
• 8.3. Asia-Pacific Biopharmaceutical Excipients Market
  • 8.3.1. China Biopharmaceutical Excipients Market
  • 8.3.2. India Biopharmaceutical Excipients Market
  • 8.3.3. Japan Biopharmaceutical Excipients Market
  • 8.3.4. Australia Biopharmaceutical Excipients Market
  • 8.3.5. South Korea Biopharmaceutical Excipients Market
  • 8.3.6. Rest of Asia Pacific Biopharmaceutical Excipients Market
• 8.4. Latin America Biopharmaceutical Excipients Market
  • 8.4.1. Brazil Biopharmaceutical Excipients Market
  • 8.4.2. Mexico Biopharmaceutical Excipients Market
  • 8.4.3. Rest of Latin America Biopharmaceutical Excipients Market
• 8.5. Middle East & Africa Biopharmaceutical Excipients Market
  • 8.5.1. Saudi Arabia Biopharmaceutical Excipients Market
  • 8.5.2. South Africa Biopharmaceutical Excipients Market
  • 8.5.3. Rest of Middle East & Africa Biopharmaceutical Excipients Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. BASF SE
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Market Strategies
  • 9.3.2. Ashland Global Holdings Inc.
  • 9.3.3. Roquette Freres S.A.
  • 9.3.4. Colorcon, Inc.
  • 9.3.5. Croda International PLC
  • 9.3.6. The Dow Chemical Company
  • 9.3.7. Merck KGaA
  • 9.3.8. Evonik Industries AG
  • 9.3.9. SPI Pharma, Inc.
  • 9.3.10. IMCD N.V.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes